Survival in patients with advanced non-small-cell lung cancer receiving supportive care

Journal of the Medical Association of Thailand

Volumn 82, Issue 4, 1999, Pages 336-340

  Riantawan, Pratheep ^a   Titayanpong, Arnon ^a   Chaisuksuwan, Rattana ^a  

^a Central Chest Hospital Thailand   (Thailand)

Author keywords

Lung cancer; Non small cell type; Survival

Indexed keywords

ARTICLE; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; MORTALITY; STATISTICS; SURVIVAL; SURVIVAL RATE; TERMINAL CARE;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; SURVIVAL RATE; TERMINAL CARE;

EID: 0033112835     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Riantawan P, Tungsagunwattana S, Subhannachart P, Yodtasurodom C. Histologic types, staging, resectability, and smoking among Thai patients with lung cancer. J Med Assoc Thai 1999; 82: 121-5.
2. Parker S, Tong T, Bolden S, Wingo P. Cancer statistics, 1996. CA Cancer J Clin 1996; 46: 5-27.
3. Souquet PJ, Chauvin F, Boissel JP, et al. Polychemotherapy in advanced non-small cell lung cancer: a meta-analysis. Lancet 1993; 342: 19-21.
4. Buccheri GF. Chemotherapy and survival in non-small cell lung cancer: three years later. Chest 1994; 106: 990-1.
5. Non-small cell lung cancer collaborative group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995; 311: 899-909.
6. Rapp E, Pater JL, Willan A, et al. Chemotherapy can prolong survival in patients with advanced non-small cell lung cancer-report of a Canadian multicenter randomized trial. J Clin Oncology 1988; 6: 633-41.
7. Lee JS, Scott C, Komaki R, et al. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancer. J Clin Oncology 1996; 14: 1055-64.
8. Haskell CM. Chemotherapy and survival of patients with non-small cell lung cancer: a contrary view. Chest 1991; 99: 1325-6.
9. Buccheri GF. Chemotherapy and survival in non-small cell lung cancer: the old vexata questio. Chest 1991; 99: 1328-9.
10. Coates A, Forbes J. Is chemotherapy for non-small cell lung cancer worthwhile. Lancet 1993; 342: 4.
11. Mountain CF. A new international staging system for lung cancer. Chest 1986; 89 (suppl): 225s-235s.
12. Armitage P, Berry G. Statistical methods in medical research. 3rd ed. Oxford: Blackwell scientific publication, 1994.
13. Altman DG. Practical statistics for medical research. 1st ed. London: Chapman & Hall, 1993.
14. Cellerino R, Tummarello D, Guidi F, et al. A randomised trial of alternating chemotherapy versus best supportive care in advanced non small cell lung cancer. J Clin Oncol 1991; 9: 1453-61.
15. Cormier Y, Bergeron D. Laforge J, et al. Benefit of polychemotherapy in advanced non small cell bronchogenic carcinoma. Cancer 1982; 50: 845-9.
16. Kaasa A, Lund E, Thorod E, et al. Symptomatic treatment versus combination chemotheerapy in patients with non small cell lung cancer, extensive disease. Cancer 1991; 67: 2443-7.